EU Authorised Representative Services for Medical Device & IVD Manufacturers

Selling medical devices or IVDs in Europe? If your company is based outside the EU, appointing an EU Authorised Representative (EC Rep) is a legal requirement under EU MDR 2017/745 and IVDR 2017/746. Patient Guard provides expert EU Authorised Representative services, EUDAMED support, regulatory guidance, and ongoing compliance management to help manufacturers access and maintain the European market with confidence.
Patient Guard EU Authorised Representative Services

Published: 6th July 2026

Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder and CEO)

Do You Need an EU Authorised Representative to Sell Medical Devices in Europe?

If you are a medical device or in vitro diagnostic (IVD) manufacturer based outside the European Union—whether in the UK, the United States, or the APAC region—and you are targeting the European single market, the regulatory pathway requires absolute clarity. Navigating the legal cross-currents of international compliance can be daunting, but the answer to your foundational question is definitive: Yes, you legally require an EU Authorised Representative (EC Rep).

Under Article 11 of both the EU Medical Device Regulation (MDR 2017/745) and the EU In Vitro Diagnostic Regulation (IVDR 2017/746), non-EU manufacturers cannot legally place a single device onto the EU market without formally appointing a sole EC Rep established within the Union.

However, many regulatory affairs teams and business leaders make the critical mistake of treating the EC Rep as a low-cost, hands-off “postal mailbox” service simply to tick a box for market access. Under the modern European regulatory framework, this superficial approach is a fast track to customs rejections, automated database enforcement, or catastrophic joint legal liability. To safeguard your supply chain and your business, you need a comprehensive understanding of what an EU Authorised Representative does, why the role has radically changed, and how to structure a bulletproof compliance partnership.

What Exactly is an EU Authorised Representative (EC Rep)?

An EU Authorised Representative is a legally registered corporate entity or natural person based inside the physical territory of the European Union (or operating under specific protocols like the Northern Ireland Windsor Framework). This entity acts as the primary legal liaison and point of contact between your non-EU manufacturing facility and the 27 EU Competent Authorities, National Market Surveillance Authorities, and Notified Bodies.

Because your EC Rep acts as your legal proxy within the single market, European law dictates that their official corporate identity, designated logo, and registered physical address must be explicitly and permanently displayed on your device labelling, outer packaging, and Instructions for Use (IFU).

Under Article 11, the mandate between the manufacturer and the representative cannot be a loose verbal agreement; it must be a formal, legally binding written contract that explicitly dictates a comprehensive suite of mandatory compliance tasks.

The Core Statutory Responsibilities of an EC Rep

  • Technical Documentation Verification: The representative must perform a proactive, rigorous review of your EU Declaration of Conformity and verify that your comprehensive technical files have been compiled properly in accordance with MDR or IVDR standards.
  • Documentation Retention & Accessibility: The EC Rep is legally obligated to maintain an updated clone of your technical documentation, relevant certificates, and any formal design or manufacturing amendments. This data must be kept at the immediate disposal of European Competent Authorities for at least 10 years after the last device is placed on the market (and 15 years for complex implantable devices).
  • EUDAMED Registrations & SRN Allocation: Your representative is responsible for validating your corporate registration inside the European Database on Medical Devices (EUDAMED). They must review and submit the data required to secure your Single Registration Number (SRN), which is your passport to commercial activity in Europe.
  • Vigilance, Incident Reporting & Market Surveillance: If a healthcare professional, patient, or user inside the EU experiences a adverse event or submits a complaint regarding your device, the EC Rep acts as the local intake hub. They must immediately forward this data to you and actively collaborate with your team to coordinate Field Safety Corrective Actions (FSCAs) and draft Field Safety Notices (FSNs).
  • Samples and Inspections: Upon an official request from an EU member state’s market surveillance authority, the EC Rep must facilitate the provision of device samples or grant access to the documentation required to verify product safety.

The Modern Post-Brexit Reality for UK Medical Device Manufacturers

For medical device companies headquartered in England, Scotland, or Wales, the regulatory landscape shifted permanently following the transition out of the European Union. The regulatory architecture governing Great Britain (managed by the MHRA) has fully decoupled from the European Commission’s frameworks.

A common point of confusion for British businesses involves the roles of domestic and international representatives. It is vital to understand that your UK Responsible Person (UK RP) has zero legal standing, authority, or recognition inside the European Union single market. A UK RP is strictly a domestic requirement for international companies selling into Great Britain.

If your primary manufacturing infrastructure or corporate headquarters is based in Great Britain, you are classified as an “third-country international exporter” in the eyes of European customs and member state inspectors. To clear a commercial shipment through European ports of entry (such as Rotterdam or Calais), your products must be legally backed by an active EU Authorised Representative mandate. Furthermore, under the MDR and IVDR, your designated EU Importer is legally required to physically check your packaging to ensure a valid EC Rep is clearly listed before they can clear the stock for commercial distribution.

The Northern Ireland Exception: The Windsor Framework

Under the current terms of the Windsor Framework, Northern Ireland maintains a unique regulatory status, aligning closely with EU single market rules for goods. For British manufacturers, this means that medical devices placed onto the market in Northern Ireland must comply with EU MDR or IVDR requirements. Interestingly, an EU Authorised Representative can be established inside Northern Ireland to represent a third-country manufacturer for the wider EU market, providing a unique geographic bridge for compliance operations.

The Danger of Cheap "Mailbox" Services: Joint and Several Liability

In the pre-MDR era under the old directives (MDD and IVDD), the role of the EC Rep was largely administrative. Many baseline providers operated as glorified mailboxes—charging a nominal annual fee to let manufacturers print their address on a label, while taking zero interest in the underlying technical data or clinical evidence.

The implementation of the MDR and IVDR completely obliterated this business model. To combat the distribution of non-compliant or hazardous devices, the European Commission introduced Article 11(5), which represents one of the heaviest regulatory shifts in modern corporate law:

Article 11(5) MDR/IVDR: Without prejudice to paragraph 4 of this Article, where the manufacturer is not established in a Member State and has not complied with its obligations under Article 10, the authorised representative shall be legally liable for defective devices on the same basis as, and jointly and severally with, the manufacturer.

This means that if your medical device malfunctions, causes patient harm, or faces an enforcement lawsuit inside the EU, and your company is outside European borders, your EU Authorised Representative is held fully, legally, and financially liable for the damages alongside you.

EU Authorised Representative

Because of this profound legal exposure, any high-quality, professional, and competent EC Rep must behave as an active, critical auditor of your business. If a third-party regulatory provider offers you an incredibly cheap, hands-off “address-only” service with no initial technical file audit, they are demonstrating a dangerous lack of understanding of European law. Alternatively, they will likely terminate your mandate instantly at the first sign of an enforcement query or Notified Body audit deficiency to protect their own corporate insurance, leaving your European sales completely stranded.

The Intersecting Role: The PRRC and the EC Rep

Another layer of topical compliance that manufacturers must navigate is the requirement for a Person Responsible for Regulatory Compliance (PRRC), as mandated by Article 15 of the MDR/IVDR. Both the non-EU manufacturer and their appointed EU Authorised Representative must have continuous and permanent access to their own respective PRRCs.

Attribute

Manufacturer’s PRRC

Authorised Representative’s PRRC

Location

Can be outside the EU (at the manufacturing site)

Must be physically located and resident inside the European Union

Core Duty

Ensures batch conformity, technical file up-keep, and post-market vigilance compliance

Verifies that the EC Rep’s statutory obligations under the Article 11 mandate are being executed

Relationship

Direct employee or outsourced (for micro/small enterprises)

Independent check-and-balance verifying the manufacturer’s compliance status

When setting up your EU infrastructure, your EC Rep will require proof that your internal PRRC is qualified (via appropriate regulatory degrees or verified professional experience) and formally designated in your quality management system (QMS).

Step-by-Step: The Onboarding Process for an EC Rep Mandate

Transitioning to an EU Authorised Representative or setting up a new mandate requires a structured approach to avoid registration gaps. The onboarding protocol should follow a highly controlled sequence:

1.Comprehensive Technical Dossier Review:

Before signing a mandate, your technical documentation, CE certificates, EU Declaration of Conformity, and device labeling layout must undergo a comprehensive gap analysis to ensure alignment with modern MDR/IVDR criteria.

2.Formal Execution of the Article 11 Mandate:

Both corporate entities draft and execute the formal written agreement, explicitly detailing the scope of devices covered by their unique Basic UDI-DIs and establishing the joint vigilance protocols.

3.EUDAMED Economic Operator Registration:

The EC Rep submits the relationship connection within the EUDAMED actor module. This application is routed to the representative’s local national Competent Authority for formal verification, leading to the generation or update of your Single Registration Number (SRN).

4.Artwork Update and Labelling Release :

The manufacturer updates all relevant device labelling, packaging artwork, and digital Instructions for Use (IFUs) to explicitly display the newly appointed EC Rep’s name and physical European address.

Critical Timeline Alert: EUDAMED Mandatory Transition and Market Enforcement

The European medical device regulatory ecosystem is entering a phase of strict enforcement regarding digital data transparency. The historical transition periods allowing for paper-based or localized tracking are drawing to an end as the European Commission accelerates the mandatory rollout of the EUDAMED database modules (specifically Actor Registration, UDI/Device Registration, and Notified Bodies/Certificates).

Moving forward, economic operators—including all international manufacturers and their appointed EU Authorised Representatives—must fully populate their device portfolios and unique device identifiers (UDI-DI) within the centralized portal.

National market surveillance authorities and customs border agents across the 27 member states are actively utilizing EUDAMED to perform spot-checks on inbound commercial shipments. If an overseas manufacturer’s portfolio is not cleanly linked to an approved, active, and verified EU Authorised Representative actor profile within the database, the shipment faces automatic border impoundment, administrative fines, and immediate removal from local hospital supply networks.

How Patient Guard Secures Your European Market Footprint

Appointing an EU Authorised Representative is not a simple, hands-off administrative transaction; it is a foundational, long-term operational partnership that dictates the security of your international revenue streams.

At Patient Guard, we function as a professional services business rather than a generic administrative registry. We provide global medical device and IVD manufacturers with a seamless, highly integrated bridge into both the United Kingdom and European single markets through our advanced regulatory compliance infrastructure and seasoned in-house auditing teams.

When you partner with Patient Guard for your EU Authorised Representative representation, you secure:

  • Proactive Pre-Market Technical Verification: Our senior regulatory specialists perform an exhaustive, independent technical audit of your technical files, clinical evaluations, and label layouts. This drastically reduces the risk of sudden Notified Body pushback or costly custom border holds before your legal mandate goes live.
  • End-to-End EUDAMED Database Management: We assume full responsibility for your EUDAMED actor profile setup, relationship mapping, and ongoing UDI data population, securing your Single Registration Number (SRN) with absolute clarity and zero hidden administrative overheads.
  • Active Regulatory Intelligence & Surveillance Support: We actively monitor the constantly evolving landscape of EU member state competent authority mandates, ensuring that your corporate Quality Management System (QMS) and post-market surveillance (PMS) strategies remain completely updated in real-time.
  • Dual-Market Harmonization: For businesses targeting both Great Britain and continental Europe, our infrastructure allows you to centralize your UK Responsible Person (UK RP) duties and your European EC Rep obligations under a single, highly coordinated professional consultancy team, eliminating fractured communication and redundant compliance spend.

Ready to Secure Your European Launch?

Do not let escalating regulatory bottlenecks, evolving database deadlines, or sub-standard technical representation disrupt your global supply chain. Speak with our specialized medical device and IVD regulatory team today to establish a secure, fully compliant EU Authorised Representative framework for your product portfolio.

Frequently Asked Questions About EU Authorised Representatives

Yes. Under Article 11 of EU MDR 2017/745 and IVDR 2017/746, manufacturers established outside the European Union must appoint an EU Authorised Representative before placing medical devices or IVDs on the EU market. Without an appointed EC Rep, products cannot legally be marketed within the EU.

 

An EU Authorised Representative represents non-EU manufacturers within the European Union and fulfils obligations under the EU MDR and IVDR. A UK Responsible Person represents non-UK manufacturers placing devices on the Great Britain market under UK medical device regulations. One appointment does not replace the other if you sell in both markets.

Yes. Manufacturers can transfer to a new EU Authorised Representative at any time, provided the existing mandate is formally terminated, a new Article 11 mandate is signed, EUDAMED records are updated where applicable, and product labelling is amended to display the new representative's details.

 

Yes. Under Article 11(5) of the MDR and IVDR, an EU Authorised Representative may share joint and several liability with the manufacturer if the manufacturer fails to meet its regulatory obligations. This is why reputable EC Reps conduct technical documentation reviews and ongoing compliance monitoring rather than simply providing a postal address.

Medical devices sold in the European Union must display the name and address of the appointed EU Authorised Representative on the device label, packaging and, where applicable, the Instructions for Use (IFU). The information must remain accurate throughout the product's lifecycle.

Your EU Authorised Representative plays a key role in supporting EUDAMED registration, including Economic Operator registration and obtaining your Single Registration Number (SRN). They also help ensure your regulatory information remains accurate as EUDAMED modules become fully mandatory.

Choose an EU Authorised Representative with proven expertise in EU MDR and IVDR, experienced regulatory specialists, comprehensive technical documentation reviews, EUDAMED support, post-market surveillance expertise, and robust professional indemnity insurance. Avoid providers offering low-cost "mailbox" services that do not actively assess your compliance.

References

This guide is based on the following legislation and official regulatory guidance relating to EU Authorised Representatives, economic operators and market access under the European Medical Devices Regulation (MDR).

Organisation Reference Why it's relevant
European Union Regulation (EU) 2017/745 on Medical Devices (MDR) Contains Article 11, which establishes the legal requirement to appoint an EU Authorised Representative for manufacturers established outside the European Union and defines their responsibilities.
European Union Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR) Establishes equivalent Authorised Representative requirements for manufacturers of in vitro diagnostic medical devices placing products on the EU market.
European Commission Authorised Representatives, Importers and Distributors Explains the roles, legal responsibilities and interactions of Authorised Representatives, importers and distributors under the MDR and IVDR, including lifecycle responsibilities and delegated tasks.
European Commission EUDAMED – European Database on Medical Devices Provides official information on EUDAMED, supporting manufacturer registration, device registration, traceability and regulatory transparency under the MDR.
European Commission MDCG Endorsed Documents and Other Guidance Provides official Medical Device Coordination Group (MDCG) guidance supporting implementation of Article 11, economic operator responsibilities and other MDR requirements.
European Commission Economic Operators Provides an overview of the obligations of manufacturers, Authorised Representatives, importers and distributors, supporting the discussion of shared regulatory responsibilities throughout the product lifecycle.

Requirements relating to EU Authorised Representatives and other economic operators continue to evolve through legislation and regulatory guidance. Manufacturers should always consult the latest published legislation and official guidance when appointing an Authorised Representative and maintaining compliance under the MDR and IVDR.

David Small BSc (Hons), MSc, MTOPRA

David Small BSc (Hons), MSc, MTOPRA

Reviewed by
David Small, BSc (Hons), MSc, MTOPRA
Founder & CEO |
20+ years in medical device regulatory affairs,  MDR/IVDR compliance and quality systems.

Patient Guards Recent Posts

Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance

Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.

Read More »

IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up

Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.

Read More »

IVDR Scientific Validity Explained: A Complete Guide for Manufacturers

Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.

Read More »

Need Training?

Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.

Share this guide:
Posted on Google Google
Munna P profile picture
Munna P
52 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Working with the Patient Guard team has been a great experience throughout our MHRA and ISO 13485 documentation journey. Their expertise, structured approach, and practical guidance helped our team build a robust quality management system while keeping us aligned with regulatory expectations. The collaboration was professional, responsive, and focused on finding solutions rather than simply identifying issues. A special thank you to Alex and Steve for their outstanding coordination, responsiveness, and continuous support throughout the project. They were always approachable, provided valuable feedback, and worked closely with our team to resolve challenges efficiently. Their commitment made a significant difference in keeping our documentation effort on track. I highly recommend Patient Guard to any healthcare or MedTech organization looking for experienced regulatory and quality system partners for MHRA, ISO 13485, and broader medical device compliance initiatives. Thank you again to the entire Patient Guard team for being such reliable partners.
Posted on Google Google
Peter Reeve profile picture
Peter Reeve
79 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
STEPPER design, manufacture & distribute eyewear across the globe. With the increasingly complex landscape concerning the placing of Mecial Devices onto the market, we realised we needed professional guidance. We found Patient Guard via a simple internet search and are delighted we did! They provide a pragmatic solution to our needs, are totally reliable & always available to answer our (often simplistic) questions. They are highly efficient & responsive to what is a changing picture in our world and nothing is too much trouble. We have a much better understanding of regulatory affairs and our responsibilities as manufacturers & distributors and they support us in navigating the requirements in different territories. Updating our Declaration of Conformity, ensuring our labelling is compliant and acting as our PRRC are the key areas of their service for us.
Posted on Google Google
Derek Timm profile picture
Derek Timm
79 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
For those companıes lookıng to comply to ISO standards and ın partıcular ISO13485 whıch to be honest ıs a nıghtmare I would strongly suggest goıng to the professıonals as ındeed we dıd by joınıng forces wıth Patıent Guard Ltd The staff are fantastıc nothıng ıs too much trouble and as a medıcal supply company we sımply cannot lıve wıthout them Thanks ın partıcular to Alex and Steve for all the hard work and our best regards from Dan Medıca South Lımıted
Posted on Google Google
BMSCriticalCare profile picture
BMSCriticalCare
116 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Great service, very helpful and always willing to answer any questions we have,
Posted on Google Google
Thomson Software profile picture
Thomson Software
787 days ago
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Alex Lewis of PatientGuard guided us through the ISO13485 process in a thorough, systematic and efficient manner. He was friendly, patient and willing to go the extra mile. Excellent service.
Verified by Trustindex
Trustindex verified badge is the Universal Symbol of Trust. Only the greatest companies can get the verified badge who has a review score above 4.5, based on customer reviews over the past 12 months. Read more

Most Popular

Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance

Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.

Read More »

IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up

Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.

Read More »

IVDR Scientific Validity Explained: A Complete Guide for Manufacturers

Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.

Read More »

IVDR Performance Evaluation Explained: A Complete Guide for Manufacturers

Performance Evaluation is one of the most important requirements under the EU In Vitro Diagnostic Regulation (IVDR). Every manufacturer must demonstrate that their in vitro diagnostic medical device achieves its intended purpose through robust scientific validity, analytical performance and clinical performance evidence. This guide explains every stage of IVDR Performance Evaluation, including Performance Evaluation Plans (PEPs), Performance Evaluation Reports (PERs), Post-Market Performance Follow-up (PMPF) and how Performance Evaluation supports successful CE marking under Regulation (EU) 2017/746.

Read More »
patient guard
Patient Guard

Sign up to our newsletter

Be the first to hear industry news and how Patient Guard can help you.

Get the latest updates on medical device regulation

Sign up to our newsletter and we’ll deliver news and insights straight to your inbox.

Get the Medical Device Technical Checklist

Thank you! The checklist is now ready to download.